Skip to main content

Bioceres Crop Solutions Corp.

For the period ended Sep 8, 2025. Filed Sep 9, 2025.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Sep 8, 2025 · Filed Sep 9, 2025

Use the contents to explore the available documents and sections.

BIOX$0.23+10.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.2 · Estimation of fair value

Estimation of fair value

The fair value of marketable securities, mutual funds, stocks and U.S. Treasury bills is calculated using the market approach based on market quotations of identical assets. The quoted market price used for financial assets held by the Group is the current offered price. These instruments are included in Level 1.

The Group's financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information and, therefore, rely as little as possible on entity-specific estimates. If all significant inputs required to value an instrument are observable, the instruments are included in Level 2.

If one or more of the significant inputs are not based on observable market data, the instruments are included in Level 3.

The Group's policy is to recognize transfers between different categories of the fair value hierarchy as they occur or when there are changes in the circumstances that trigger the transfer. No transfers occurred between fair value levels. There have been no changes in economic or business circumstances that affect fair value.

16.SHARE BASED PAYMENTS
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.